Refresh Lacri-Lube eye ointment recalled due to possible risk of infection

AbbVie Corporation of Canada is recalling all lots of Refresh Lacri-Lube eye ointment because some tubes may leak, which could lead to contamination with bacteria and other microbes and the risk of infection. Seniors and those with a weakened immune system may be at a higher risk.

Refresh Lacri-Lube is an over-the-counter sterile eye lubricant used to temporarily relieve eye burning, irritation and discomfort due to dryness or exposure to wind or sun. Some tubes of the affected product were observed to be leaking from the bottom due to an opening in the seal.

For healthy people, the risk of a serious eye infection due to a contaminated eye ointment is relatively low and any infection may resolve on its own. If the infection does not resolve on its own, it would often be treatable with topical antibiotics. In rare cases, eye infections can lead to severe outcomes including vision loss, and systemic infections. This risk is higher for people more susceptible to infection. Signs of infection may include eye pain, changes in vision, light sensitivity, redness of the eye, excessive discharge and abnormal pupils. Other symptoms include fever, or facial pain or pressure.

Health Canada is monitoring the company's recall and its implementation of corrective and preventive actions. The Department will inform the public if any new health risks are identified.